CHOROIDAL THICKNESS AFTER FULL-FLUENCE AND HALF-FLUENCE PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Retina. 2015 Aug;35(8):1555-60. doi: 10.1097/IAE.0000000000000511.

Abstract

Purpose: To compare clinical outcomes after full-fluence and half-fluence photodynamic therapy (PDT) in chronic central serous chorioretinopathy, focusing on changes in subfoveal choroidal thickness (SFCT) using enhanced depth imaging optical coherence tomography.

Methods: Retrospective, comparative interventional case series.

Results: In the full-fluence (n = 25) and half-fluence groups (n = 43), SFCT decreased from 351 ± 70 μm and 362 ± 63 μm at baseline to 276 ± 65 μm and 322 ± 70 μm at 3 months and remained at 267 ± 66 μm and 318 ± 76 μm at 12 months, respectively (all P < 0.001, for each comparison with baseline). The change in SFCT was greater in the full-fluence group than in the half-fluence group (P = 0.001). In the half-fluence group, SFCT was thicker in the treated eye than in the fellow eye (P = 0.045), whereas in the full-fluence group, the difference in SFCT was not significant (P = 0.209). Best-corrected visual acuity and central retinal thickness improved after PDT in both groups (all P < 0.001). However, the differences between the groups were not significant (P = 0.873 and P = 0.124, respectively).

Conclusion: The results at 1 year show that full-fluence PDT reduces SFCT more than half-fluence PDT, and that SFCT after half-fluence PDT was still thicker than that in the fellow eye. The clinical implications of this finding for long-term outcomes including recurrence rate remain to be elucidated.

MeSH terms

  • Aged
  • Central Serous Chorioretinopathy / drug therapy*
  • Choroid / pathology*
  • Chronic Disease
  • Female
  • Fluorescein Angiography
  • Humans
  • Male
  • Middle Aged
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage
  • Porphyrins / administration & dosage
  • Retina / pathology
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Verteporfin
  • Visual Acuity / physiology

Substances

  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin